Table 2.
Demographics and procedural variables compared by sex.
| Variable | Men (n = 7498) | Women (n = 3917) | p‐value |
|---|---|---|---|
| Age, years | 63.1 ± 12.4 | 66.1 ± 12 | < 0.001 |
| White | 6899 (92.0%) | 3475 (88.7%) | < 0.001 |
| Black | 447 (6%) | 387 (9.9%) | < 0.001 |
| Asian | 95 (1.3%) | 33 (0.8%) | 0.04 |
| Body mass index, kg/m2 | 30.8 ± 8 | 31.5 ± 9 | < 0.001 |
| Diabetes mellitus | 3135 (41.8%) | 1915 (48.9%) | < 0.001 |
| Hypertension | 6121 (81.6%) | 3357 (85.7%) | < 0.001 |
| Hyperlipidemia | 5829 (77.7%) | 3156 (80.6%) | < 0.001 |
| Prior stroke | 873 (11.6%) | 644 (16.4%) | < 0.001 |
| Peripheral vascular disease | 1170 (15.6%) | 641 (16.4%) | 0.29 |
| Prior PCI | 3566 (47.6%) | 1717 (43.8%) | < 0.001 |
| Prior CABG | 1777 (23.7%) | 644 (16.4%) | < 0.001 |
| Chronic lung disease | 1104 (14.7%) | 757 (19.3%) | < 0.001 |
| End‐stage renal disease | 413 (5.5%) | 227 (5.8%) | 0.52 |
| Cardiac arrest | 255 (3.4%) | 111 (2.8%) | 0.1 |
| ST‐elevation myocardial infarction | 1841 (24.6%) | 800 (20.4%) | < 0.001 |
| Non‐ST‐elevation myocardial infarction | 2075 (27.7%) | 1254 (32%) | < 0.001 |
| Glycoprotein IIb/IIIa inhibitor | 1261 (16.8%) | 557 (14.2%) | < 0.001 |
Note: Values are mean ± SD or n (%). Abbreviations: CABG, coronary artery bypass grafting; PCI, percutaneous coronary intervention